|
業務類別
|
-- |
|
業務概覽
|
AnGes Inc is a biopharmaceutical company. The company's development projects include - HGF plasmid, NFkB decoy oligonucleotide, and Therapeutic vaccine. |
| 公司地址
| 7-7-15, Saito-asagi, 4F, Saito Bio-Incubator, Ibaraki, Osaka, JPN, 567-0085 |
| 電話號碼
| -- |
| 傳真號碼
| -- |
| 公司網頁
| http://www.anges.co.jp |
| 員工數量
| 41 |
| Dr. Ei Yamada, M.D.,PhD |
Director, Chief Executive Officer and President |
-- |
25/03/2026 |
| Mr. Naoya Sato |
Director and General Manager, Administration Department |
-- |
25/03/2026 |
|
|
| Mr. Akira Kondo |
Independent Director |
25/03/2026 |
| Ms. Naomi Watanabe |
Independent Director |
25/03/2026 |
| Ms. Satomi Akabane |
Independent Director |
25/03/2026 |
| Dr. Ei Yamada, M.D.,PhD |
Director, Chief Executive Officer and President |
25/03/2026 |
| Mr. Naoya Sato |
Director and General Manager, Administration Department |
25/03/2026 |
|
|
|
|
